A detailed history of Virginia Retirement Systems Et Al transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Virginia Retirement Systems Et Al holds 16,600 shares of BEAM stock, worth $419,814. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,600
Previous 15,900 4.4%
Holding current value
$419,814
Previous $507,000 21.3%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Jan 02, 2024

BUY
$23.01 - $32.46 $16,107 - $22,722
700 Added 4.4%
16,600 $399,000
Q2 2023

Aug 22, 2023

BUY
$29.32 - $35.99 $8,796 - $10,797
300 Added 1.92%
15,900 $507,000
Q1 2023

Jul 11, 2023

BUY
$30.15 - $48.79 $301,500 - $487,900
10,000 Added 178.57%
15,600 $477,000
Q4 2022

May 17, 2023

SELL
$36.73 - $51.6 $106,516 - $149,640
-2,900 Reduced 34.12%
5,600 $219 Million
Q3 2022

May 16, 2023

BUY
$39.79 - $70.31 $338,215 - $597,635
8,500 New
8,500 $405 Million

Others Institutions Holding BEAM

About Beam Therapeutics Inc.


  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $1.78B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Virginia Retirement Systems Et Al Portfolio

Follow Virginia Retirement Systems Et Al and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Virginia Retirement Systems Et Al with notifications on news.